Tim Fischer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tim Fischer has a total of 202 co-authors. Here are the top co-authors by number of shared publications:
- Stephan Waelti
Department of Radiology and Nuclear Medicine, Children’s Hospital of Eastern Switzerland, St. Gallen, Switzerland
11 shared publications - Tobias Johannes Dietrich
Division of Radiology and Nuclear Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
11 shared publications - Simon Wildermuth
Division of Radiology and Nuclear Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
10 shared publications - Sebastian Leschka
Division of Radiology and Nuclear Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
8 shared publications - Gian-Reto Kleger
Department of Intensive Care Medicine, Cantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland
4 shared publications - Stefan Markart
Department of Radiology and Nuclear Medicine, Children’s Hospital of Eastern Switzerland, St. Gallen, Switzerland
4 shared publications
Latest Publications
- 15 September 2026
- Published by Elsevier in Radiography
- Vol. 32 (7)
CT-imaging of variants of the medial clavicular epiphysis in a central European population: prevalence and impact on forensic age estimation
- 15 September 2026
- Published by Elsevier in Radiography
- Vol. 32 (7)
CT-imaging of variants of the medial clavicular epiphysis in a central European population: prevalence and impact on forensic age estimation
- Open Access
- 4 March 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (4) , 901-909
Follow-up imaging after hospital discharge for acute intracerebral hemorrhage in European academic hospitals: a decision-making analysis
Purpose To investigate factors guiding follow-up imaging after hospital discharge in atraumatic intracerebral hemorrhage (ICH) across large European academic centers and compare decision-making patterns using a standardized approach. Methods Expert neuroradiologists from nine European centers in eight countries detailed their follow-up algorithms for deep and lobar ICH, specifying (1) patient-related decision criteria, (2) preferred imaging modalities, and (3) advised follow-up timing. Free-text and schematic inputs were harmonized into uniform decision trees, mapping recommended modalities (CT, MRI/MRA, DSA, CTA) to patient-factor constellations. The primary endpoint was the distribution of recommended strategies; the secondary endpoint was inter-center consensus (≥ 50% agreement). Results Key decision criteria were hemorrhage location, suspected structural macrovascular pathology (SMVP), age, hypertension, and small-vessel disease. MRI/MRA was recommended by all centers and appeared in nearly all decision branches; “no further imaging” was rare. Additional strategies variably combined MRI/MRA with DSA and/or CTA, whereas stand-alone DSA as first follow-up test was uncommon. Formal consensus was achieved in a minority of clinical scenarios, most consistently for deep ICH, where MRI/MRA reached around 60% support. In young patients with lobar ICH and suspected SMVP, no single strategy reached consensus. The most frequently proposed timepoint for follow-up imaging was 6–12 weeks after discharge. Conclusion In current European practice, MRI/MRA at 6–12 weeks represents the predominant follow-up strategy after ICH discharge, with CTA ± DSA added when SMVP is suspected. Despite this MRI-centered pattern, substantial inter-center heterogeneity persists, underscoring the need for standardized follow-up imaging with clearly defined timelines and protocols.
- 4 March 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (4) , 901-909
Open AccessFollow-up imaging after hospital discharge for acute intracerebral hemorrhage in European academic hospitals: a decision-making analysis
Purpose To investigate factors guiding follow-up imaging after hospital discharge in atraumatic intracerebral hemorrhage (ICH) across large European academic centers and compare decision-making patterns using a standardized approach. Methods Expert neuroradiologists from nine European centers in eight countries detailed their follow-up algorithms for deep and lobar ICH, specifying (1) patient-related decision criteria, (2) preferred imaging modalities, and (3) advised follow-up timing. Free-text and schematic inputs were harmonized into uniform decision trees, mapping recommended modalities (CT, MRI/MRA, DSA, CTA) to patient-factor constellations. The primary endpoint was the distribution of recommended strategies; the secondary endpoint was inter-center consensus (≥ 50% agreement). Results Key decision criteria were hemorrhage location, suspected structural macrovascular pathology (SMVP), age, hypertension, and small-vessel disease. MRI/MRA was recommended by all centers and appeared in nearly all decision branches; “no further imaging” was rare. Additional strategies variably combined MRI/MRA with DSA and/or CTA, whereas stand-alone DSA as first follow-up test was uncommon. Formal consensus was achieved in a minority of clinical scenarios, most consistently for deep ICH, where MRI/MRA reached around 60% support. In young patients with lobar ICH and suspected SMVP, no single strategy reached consensus. The most frequently proposed timepoint for follow-up imaging was 6–12 weeks after discharge. Conclusion In current European practice, MRI/MRA at 6–12 weeks represents the predominant follow-up strategy after ICH discharge, with CTA ± DSA added when SMVP is suspected. Despite this MRI-centered pattern, substantial inter-center heterogeneity persists, underscoring the need for standardized follow-up imaging with clearly defined timelines and protocols.
- Open Access
- 17 February 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 52
Primary angiitis of the central nervous system: predictors of stroke during immunosuppressant treatment
Objective: To evaluate predictors of ischemic stroke in patients with primary angiitis of the central nervous system after initiation of immunosuppressive therapy. Materials and methods: This retrospective study included 204 MRI examinations of 23 patients with primary angiitis of the central nervous system, treated with immunosuppressive therapy between 2015 and 2020 at the University Hospital Bern and the Cantonal Hospital St. Gallen, Switzerland. Two senior neuroradiologists evaluated the MRI exams with regard to the occurrence and location of ischemic stroke and hemorrhage, as well as the following characteristics of inflamed vessels on 3D time-of-flight angiography and T1 dark-blood post contrast: signal intensity of vessel walls, length of enhancement, circular extent of enhancement, and stenosis. After matching ischemic strokes to their corresponding vessel, the temporal relationship of vessel alterations in accordance with therapy initiation and stroke onset was calculated. Results: The majority (77.6%) of observed strokes were in the vascular territory of an inflamed vessel. A significant, non-linear temporal relationship between the timing of MRI and the initiation of immunosuppression was found. The highest predicted probability of ischemic stroke was observed between 10 and 20 days after the initiation of immunosuppressant therapy, reaching approximately 12%. Out of all evaluated vessel characteristics, a higher degree of stenosis (Estimate: 0.93, p = 0.006) and a higher circularity of enhancement (Estimate: 0.76, p = 0.01) were significantly associated with a higher likelihood of stroke. Conclusions: A better understanding of unfavorable constellations (critical timeframe, characteristic vessel wall changes) in patients treated for primary angiitis of the central nervous system may help to prevent secondary ischemic strokes. Critical relevance statement: A better understanding of ischemic stroke predictors in patients treated for primary angiitis of the central nervous system may prompt closer monitoring or therapy adjustment. Key Points: To evaluate risk factors for ischemic stroke in patients treated for primary angiitis of the central nervous system. Higher degree of stenosis and circular enhancement are associated with a higher likelihood of ischemic strokes, which typically occur between 10 and 20 days after therapy onset. Data obtained from this may prompt closer monitoring or therapy adjustment. Graphical
- 17 February 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 52
Open AccessPrimary angiitis of the central nervous system: predictors of stroke during immunosuppressant treatment
Objective: To evaluate predictors of ischemic stroke in patients with primary angiitis of the central nervous system after initiation of immunosuppressive therapy. Materials and methods: This retrospective study included 204 MRI examinations of 23 patients with primary angiitis of the central nervous system, treated with immunosuppressive therapy between 2015 and 2020 at the University Hospital Bern and the Cantonal Hospital St. Gallen, Switzerland. Two senior neuroradiologists evaluated the MRI exams with regard to the occurrence and location of ischemic stroke and hemorrhage, as well as the following characteristics of inflamed vessels on 3D time-of-flight angiography and T1 dark-blood post contrast: signal intensity of vessel walls, length of enhancement, circular extent of enhancement, and stenosis. After matching ischemic strokes to their corresponding vessel, the temporal relationship of vessel alterations in accordance with therapy initiation and stroke onset was calculated. Results: The majority (77.6%) of observed strokes were in the vascular territory of an inflamed vessel. A significant, non-linear temporal relationship between the timing of MRI and the initiation of immunosuppression was found. The highest predicted probability of ischemic stroke was observed between 10 and 20 days after the initiation of immunosuppressant therapy, reaching approximately 12%. Out of all evaluated vessel characteristics, a higher degree of stenosis (Estimate: 0.93, p = 0.006) and a higher circularity of enhancement (Estimate: 0.76, p = 0.01) were significantly associated with a higher likelihood of stroke. Conclusions: A better understanding of unfavorable constellations (critical timeframe, characteristic vessel wall changes) in patients treated for primary angiitis of the central nervous system may help to prevent secondary ischemic strokes. Critical relevance statement: A better understanding of ischemic stroke predictors in patients treated for primary angiitis of the central nervous system may prompt closer monitoring or therapy adjustment. Key Points: To evaluate risk factors for ischemic stroke in patients treated for primary angiitis of the central nervous system. Higher degree of stenosis and circular enhancement are associated with a higher likelihood of ischemic strokes, which typically occur between 10 and 20 days after therapy onset. Data obtained from this may prompt closer monitoring or therapy adjustment. Graphical
- Open Access
- 7 February 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (6) , 1297-1307
Impact of calcium suppression imaging on hand and wrist fracture detection in spectral CT: a comparison with X-ray and CT
Objectives To evaluate the impact of calcium suppression (CaSupp) imaging of spectral computed tomography (SpCT) on fracture detection in clinical routine in the acute trauma setting of the hand and wrist. Materials and methods Retrospective inclusion of 125 patients who underwent both X-ray and SpCT examinations of the hand and wrist in an acute trauma setting. Two independent readers evaluated fracture presence on X-ray, conventional CT, and conventional CT plus CaSupp images (time interval 4 weeks, each). Bone bruise (BBr) presence was evaluated on CaSupp images. Sensitivity and specificity were calculated according to the consensus reading as the reference standard. Results Of the 125 patients (mean age, 55 years ± 19.5 [SD]; 67 female), 120 presented with at least one fracture, for a total of 212 fractured bones. Sensitivity was increased significantly for both readers in CT + CaSupp (94.3 and 97.2%) compared to conventional CT (88.2 and 90.1%, p < .01) and X-ray (72.6 and 75.9%, p < .01). Specificity was 99.9 and 100% for CT + CaSupp, 99.8 and 99.9% for conventional CT, and 99.4 and 99.9% for X-ray. Reader 1 detected 13 additional fractures in CT + CaSupp compared to conventional CT alone, while Reader 2 detected 15 additional fractures. BBr was seen in 58% of all fractures, in 76% of multifragmentary fractures, and in 13% of avulsion fractures. Inter-reader κ was almost perfect for X-ray (κ = .85), CT and CT + CaSupp (κ = .95), and substantial for BBr (κ = .61). Conclusion CaSupp images in combination with conventional CT images significantly improved sensitivity for acute trauma fracture detection in the hand and wrist compared to conventional CT images alone and X-ray.
- 7 February 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (6) , 1297-1307
Open AccessImpact of calcium suppression imaging on hand and wrist fracture detection in spectral CT: a comparison with X-ray and CT
Objectives To evaluate the impact of calcium suppression (CaSupp) imaging of spectral computed tomography (SpCT) on fracture detection in clinical routine in the acute trauma setting of the hand and wrist. Materials and methods Retrospective inclusion of 125 patients who underwent both X-ray and SpCT examinations of the hand and wrist in an acute trauma setting. Two independent readers evaluated fracture presence on X-ray, conventional CT, and conventional CT plus CaSupp images (time interval 4 weeks, each). Bone bruise (BBr) presence was evaluated on CaSupp images. Sensitivity and specificity were calculated according to the consensus reading as the reference standard. Results Of the 125 patients (mean age, 55 years ± 19.5 [SD]; 67 female), 120 presented with at least one fracture, for a total of 212 fractured bones. Sensitivity was increased significantly for both readers in CT + CaSupp (94.3 and 97.2%) compared to conventional CT (88.2 and 90.1%, p < .01) and X-ray (72.6 and 75.9%, p < .01). Specificity was 99.9 and 100% for CT + CaSupp, 99.8 and 99.9% for conventional CT, and 99.4 and 99.9% for X-ray. Reader 1 detected 13 additional fractures in CT + CaSupp compared to conventional CT alone, while Reader 2 detected 15 additional fractures. BBr was seen in 58% of all fractures, in 76% of multifragmentary fractures, and in 13% of avulsion fractures. Inter-reader κ was almost perfect for X-ray (κ = .85), CT and CT + CaSupp (κ = .95), and substantial for BBr (κ = .61). Conclusion CaSupp images in combination with conventional CT images significantly improved sensitivity for acute trauma fracture detection in the hand and wrist compared to conventional CT images alone and X-ray.
- 3 February 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (5) , 1129-1137
Prevalence and imaging characteristics of the transverse trochlear ridge on elbow MRI and radiographs in youths
Objectives The transverse trochlear ridge (TTR) is an anatomic variant of the ulnar trochlear groove. This study evaluated the prevalence and imaging characteristics of the TTR on MRI and radiographs in children, adolescents, and young adults. Materials and methods This retrospective analysis included 178 MRI examinations and 95 corresponding radiographs of patients aged 4–25 years. The presence or absence of the TTR was evaluated. The width, height, and depth of the TTR were measured. The sensitivity and specificity of radiography to detect TTRs were evaluated compared with MRI as the reference standard. Binomial logistic regression analysis was used to compare the effects of age and gender on the prevalence of TTR. Results TTR was observed on 149 of 178 (83.7%) elbow MRIs. Mean width, height, and depth were 20.6 ± 3.0 mm, 4.2 ± 1.2 mm, and 2.0 ± 0.7 mm, respectively. Comparing increasing age in years with the prevalence of the TTR revealed a statistically significant odds ratio of 1.119 (95% CI; p = 0.012). The maximum predicted probability was a prevalence of 96% for TTR at the age of 25. Sensitivity and specificity values of the TTR on radiographs were 29.6% and 92.9%. Cohen’s kappa for the inter-rater agreement for the prevalence of the TTR on MRI was 0.740. Conclusions The predicted prevalence of TTR demonstrated an age-dependent increase in the prevalence up to 17 years of age. The size of the TTR also demonstrated an age‑dependent increase during adolescence. The high frequency of TTR on MRI indicates that TTR represents a common variant.
- 3 February 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (5) , 1129-1137
Prevalence and imaging characteristics of the transverse trochlear ridge on elbow MRI and radiographs in youths
Objectives The transverse trochlear ridge (TTR) is an anatomic variant of the ulnar trochlear groove. This study evaluated the prevalence and imaging characteristics of the TTR on MRI and radiographs in children, adolescents, and young adults. Materials and methods This retrospective analysis included 178 MRI examinations and 95 corresponding radiographs of patients aged 4–25 years. The presence or absence of the TTR was evaluated. The width, height, and depth of the TTR were measured. The sensitivity and specificity of radiography to detect TTRs were evaluated compared with MRI as the reference standard. Binomial logistic regression analysis was used to compare the effects of age and gender on the prevalence of TTR. Results TTR was observed on 149 of 178 (83.7%) elbow MRIs. Mean width, height, and depth were 20.6 ± 3.0 mm, 4.2 ± 1.2 mm, and 2.0 ± 0.7 mm, respectively. Comparing increasing age in years with the prevalence of the TTR revealed a statistically significant odds ratio of 1.119 (95% CI; p = 0.012). The maximum predicted probability was a prevalence of 96% for TTR at the age of 25. Sensitivity and specificity values of the TTR on radiographs were 29.6% and 92.9%. Cohen’s kappa for the inter-rater agreement for the prevalence of the TTR on MRI was 0.740. Conclusions The predicted prevalence of TTR demonstrated an age-dependent increase in the prevalence up to 17 years of age. The size of the TTR also demonstrated an age‑dependent increase during adolescence. The high frequency of TTR on MRI indicates that TTR represents a common variant.
- 20 January 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (8) , 2099-2107
Structured reporting in knee MRI
Structured reporting in knee MRI represents a transformative advancement in musculoskeletal radiology, promising enhanced clarity and consistency in evaluating the knee’s complex anatomy—menisci, ligaments, cartilage, and bone. This review article explores the foundations, evolution, and clinical applications of structured reporting, with a special focus on its role in knee MRI. Furthermore, we examine different studies highlighting the benefits of structured reporting, like improved clinician communication and support for emerging artificial intelligence (AI) tools, while also addressing challenges like balancing structure and a certain amount of narrative flexibility. Frameworks such as anatomical versus tissue-based approaches are explored, and insights into possible best practices are offered. The outlook is promising with AI-driven automation, natural language processing, and patient-centric innovations, driven by global standardization efforts from radiological societies. Structured reporting in knee MRI invites further exploration to unlock its full potential, ultimately leading to improved patient care.
- 20 January 2026
- Published by Springer Nature in Skeletal Radiology
- Vol. 55 (8) , 2099-2107
Structured reporting in knee MRI
Structured reporting in knee MRI represents a transformative advancement in musculoskeletal radiology, promising enhanced clarity and consistency in evaluating the knee’s complex anatomy—menisci, ligaments, cartilage, and bone. This review article explores the foundations, evolution, and clinical applications of structured reporting, with a special focus on its role in knee MRI. Furthermore, we examine different studies highlighting the benefits of structured reporting, like improved clinician communication and support for emerging artificial intelligence (AI) tools, while also addressing challenges like balancing structure and a certain amount of narrative flexibility. Frameworks such as anatomical versus tissue-based approaches are explored, and insights into possible best practices are offered. The outlook is promising with AI-driven automation, natural language processing, and patient-centric innovations, driven by global standardization efforts from radiological societies. Structured reporting in knee MRI invites further exploration to unlock its full potential, ultimately leading to improved patient care.
- 30 July 2025
- Published by Elsevier in Radiography
- Vol. 31 (5) , 103106
Ossification variation of the medial clavicular epiphysis in children, adolescents and young adults
- 30 July 2025
- Published by Elsevier in Radiography
- Vol. 31 (5) , 103106
Ossification variation of the medial clavicular epiphysis in children, adolescents and young adults
- Open Access
Rethinking the Prognostic Role of Necrosis in Soft-Tissue Sarcoma: Multidisciplinary Insights from the Sarcoma Academy
Background: Soft-tissue sarcomas (STSs) represent a heterogeneous group of malignancies with widely varying treatment responses and biological behaviors. While spontaneous necrosis (present at diagnosis) is recognized in established sarcoma grading systems, the prognostic significance of therapy-induced necrosis remains uncertain. Inconsistent definitions, methodological variability, and clinical confounders further complicate the interpretation of necrosis as an independent prognostic marker. Methods: This communication synthesizes findings from an international, multidisciplinary webinar hosted by the Sarcoma Academy, critically assessing the utility of therapy-induced necrosis in STS management. Discussions encompassed surgical, pathological, oncological, and radiological perspectives, emphasizing how necrosis is defined, measured, and contextualized in patient care. Results: Heterogeneity in STS subtypes, varied treatment protocols, and sampling inconsistencies challenge the prognostic value of post-treatment necrosis. While substantial necrosis may sometimes signal effective therapy, it can also reflect the tumor’s aggressive nature. The panel underscored the utility of measuring the percentage of viable tumor cells, rather than necrosis alone, to obtain a more standardized and reproducible measure of therapy response. Emerging approaches—such as radiomics, molecular profiling, immune-based analyses, and real-world evidence (RWE) protocols—offer promising avenues for refining prognostication and guiding personalized therapy in STS. Conclusions: A focus solely on therapy-induced necrosis is insufficient to predict outcomes in STS. Instead, a multidisciplinary framework—combining standardized pathology protocols, quantification of viable tumor cells, advanced imaging, and innovative clinical trial designs—can better capture both treatment effects and underlying tumor biology. Future collaborative studies and hybrid trial methodologies are needed to determine which STS subgroups gain the most from intensified treatments aimed at maximizing necrosis, and how to balance such interventions with surgical considerations, toxicity, and overall patient well-being.
Open AccessRethinking the Prognostic Role of Necrosis in Soft-Tissue Sarcoma: Multidisciplinary Insights from the Sarcoma Academy
Background: Soft-tissue sarcomas (STSs) represent a heterogeneous group of malignancies with widely varying treatment responses and biological behaviors. While spontaneous necrosis (present at diagnosis) is recognized in established sarcoma grading systems, the prognostic significance of therapy-induced necrosis remains uncertain. Inconsistent definitions, methodological variability, and clinical confounders further complicate the interpretation of necrosis as an independent prognostic marker. Methods: This communication synthesizes findings from an international, multidisciplinary webinar hosted by the Sarcoma Academy, critically assessing the utility of therapy-induced necrosis in STS management. Discussions encompassed surgical, pathological, oncological, and radiological perspectives, emphasizing how necrosis is defined, measured, and contextualized in patient care. Results: Heterogeneity in STS subtypes, varied treatment protocols, and sampling inconsistencies challenge the prognostic value of post-treatment necrosis. While substantial necrosis may sometimes signal effective therapy, it can also reflect the tumor’s aggressive nature. The panel underscored the utility of measuring the percentage of viable tumor cells, rather than necrosis alone, to obtain a more standardized and reproducible measure of therapy response. Emerging approaches—such as radiomics, molecular profiling, immune-based analyses, and real-world evidence (RWE) protocols—offer promising avenues for refining prognostication and guiding personalized therapy in STS. Conclusions: A focus solely on therapy-induced necrosis is insufficient to predict outcomes in STS. Instead, a multidisciplinary framework—combining standardized pathology protocols, quantification of viable tumor cells, advanced imaging, and innovative clinical trial designs—can better capture both treatment effects and underlying tumor biology. Future collaborative studies and hybrid trial methodologies are needed to determine which STS subgroups gain the most from intensified treatments aimed at maximizing necrosis, and how to balance such interventions with surgical considerations, toxicity, and overall patient well-being.
- Open Access
Evaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
Patients who survive critical COVID-19 frequently report post-acute sequelae of COVID-19 (PASC) such as psychosomatic and neurocognitive health problems. The goal of this study was to identify clinical risk factors and other predictors for such long-term consequences in severely ill COVID-19 patients. Adult COVID-19 intensive care unit (ICU) survivors from August 2020 to May 2021 were enrolled. A broad range of clinical, laboratory and chest computed tomography (CT) data was collected during their ICU stays. The association between ICU predictors and psychosomatic, respiratory, and neurocognitive assessments 12 months after ICU discharge was analyzed using univariate regression analysis. In 17 patients (mean age 58.9 ± 11.4 years), laboratory markers (CRP, lymphocytes, hemoglobin), ICU severity (SOFA, SAPS II, need for mechanical ventilation), complications (ARDS), and lung CT data (ground-glass opacity) were promising predictors of depressive and anxiety symptoms, fatigue, and sleep problems. Recovery of psychosomatic health such as fatigue, depression, and anxiety correlated with lower levels of inflammation and high hemoglobin levels. ARDS, mechanical ventilation, and worse SOFA and SAPS II scores were further risk factors for depressive and anxiety symptoms. Our study identified novel associations such as pulmonary ground-glass opacity being positively associated with depression, anxiety, fatigue, and insomnia levels.
Open AccessEvaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
Patients who survive critical COVID-19 frequently report post-acute sequelae of COVID-19 (PASC) such as psychosomatic and neurocognitive health problems. The goal of this study was to identify clinical risk factors and other predictors for such long-term consequences in severely ill COVID-19 patients. Adult COVID-19 intensive care unit (ICU) survivors from August 2020 to May 2021 were enrolled. A broad range of clinical, laboratory and chest computed tomography (CT) data was collected during their ICU stays. The association between ICU predictors and psychosomatic, respiratory, and neurocognitive assessments 12 months after ICU discharge was analyzed using univariate regression analysis. In 17 patients (mean age 58.9 ± 11.4 years), laboratory markers (CRP, lymphocytes, hemoglobin), ICU severity (SOFA, SAPS II, need for mechanical ventilation), complications (ARDS), and lung CT data (ground-glass opacity) were promising predictors of depressive and anxiety symptoms, fatigue, and sleep problems. Recovery of psychosomatic health such as fatigue, depression, and anxiety correlated with lower levels of inflammation and high hemoglobin levels. ARDS, mechanical ventilation, and worse SOFA and SAPS II scores were further risk factors for depressive and anxiety symptoms. Our study identified novel associations such as pulmonary ground-glass opacity being positively associated with depression, anxiety, fatigue, and insomnia levels.
- Open Access
- 5 July 2024
- Published by MDPI AG in Preprints.org
Evaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
Patients who survived critical COVID-19 frequently reported post-acute sequelae of COVID-19 (PASC) such as psychosomatic and neurocognitive health problems. The goal of this study was to identify clinical risk factors and other predictors for such long-term consequences in severely ill COVID-19 patients. Adult COVID-19 intensive care unit (ICU) survivors from August 2020 to May 2021 were enrolled. A broad range of clinical, laboratory and chest computed tomography (CT) data was collected during ICU stay. The association between ICU predictors and psychosomatic, respiratory and neurocognitive assessments 12 months after ICU discharge was analyzed using univariate regression analysis. In 17 patients (mean age 58.9 ± 11.4 years), laboratory markers (CRP, lymphocytes, hemoglobin), ICU severity (SOFA, SAPS II, need for mechanical ventilation), complications (ARDS), and lung CT data (ground-glass opacity) were promising predictors of depressive and anxiety symptoms, fatigue, and sleep problems. Recovery of psychosomatic health such as fatigue, depression and anxiety correlated with lower levels of inflammation and high hemoglobin levels. ARDS, mechanical ventilation and worse SOFA and SAPS II scores were further risk factors for depressive and anxiety symptoms. Our study identified novel associations such as pulmonary ground-glass opacity being positively associated with depression, anxiety, fatigue, and insomnia levels.
- 5 July 2024
- Published by MDPI AG in Preprints.org
Open AccessEvaluation of Psychosomatic, Respiratory, and Neurocognitive Health in COVID-19 Survivors 12 Months after ICU Discharge
Patients who survived critical COVID-19 frequently reported post-acute sequelae of COVID-19 (PASC) such as psychosomatic and neurocognitive health problems. The goal of this study was to identify clinical risk factors and other predictors for such long-term consequences in severely ill COVID-19 patients. Adult COVID-19 intensive care unit (ICU) survivors from August 2020 to May 2021 were enrolled. A broad range of clinical, laboratory and chest computed tomography (CT) data was collected during ICU stay. The association between ICU predictors and psychosomatic, respiratory and neurocognitive assessments 12 months after ICU discharge was analyzed using univariate regression analysis. In 17 patients (mean age 58.9 ± 11.4 years), laboratory markers (CRP, lymphocytes, hemoglobin), ICU severity (SOFA, SAPS II, need for mechanical ventilation), complications (ARDS), and lung CT data (ground-glass opacity) were promising predictors of depressive and anxiety symptoms, fatigue, and sleep problems. Recovery of psychosomatic health such as fatigue, depression and anxiety correlated with lower levels of inflammation and high hemoglobin levels. ARDS, mechanical ventilation and worse SOFA and SAPS II scores were further risk factors for depressive and anxiety symptoms. Our study identified novel associations such as pulmonary ground-glass opacity being positively associated with depression, anxiety, fatigue, and insomnia levels.